Showing results (421-430 of 462) with videos related to

Sort By:
Pageof 47
Haematologica|November 4, 2021
AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemiaSean M Post, Huaxian Ma, Prerna Malaney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2013
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancerB M Wolpin, E M O'Reilly, Y J Ko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2020
Chemotherapy and COVID-19 Outcomes in Patients With CancerJustin Jee, Michael B Foote, Melissa Lumish, et al.
Leukemia & Lymphoma|July 2, 2019
The contribution of MYC and PLK1 expression to proliferative capacity in diffuse large B-cell lymphomaMing Liang Oon, Michal M Hoppe, Shuangyi Fan, et al.
Cell|September 7, 2024
TGF-β and RAS jointly unmask primed enhancers to drive metastasisJun Ho Lee, Francisco J Sánchez-Rivera, Lan He, et al.
Oncogene|February 29, 2012
Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutationsW Yuan, E Stawiski, V Janakiraman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapyM Moore, S Gill, T Asmis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced SarcomaNicholas D Klemen, Sinchun Hwang, Martina Bradic, et al.
Obesity (Silver Spring, Md.)|February 7, 2023
A two-decade population-based study on the effect of hypertension in the general population with obesity in the United StatesGwyneth Kong, Yip H Chin, Jieyu Lim, et al.
Journal for Immunotherapy of Cancer|April 2, 2022
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single centerEvan Rosenbaum, Cristina R Antonescu, Shaleigh Smith, et al.
Pageof 47